Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
Abstract Background Currently, there is no consensus on the efficacy and safety of lamivudine (LAM) plus tenofovir disoproxil fumarate (TDF) combination therapy versus lamivudine monotherapy in HBV/HIV coinfected patients. Methods A comprehensive literature search was performed in English and Chines...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2018-09-01
|
| Серии: | Virology Journal |
| Предметы: | |
| Online-ссылка: | http://link.springer.com/article/10.1186/s12985-018-1050-3 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|